One of the great challenges for treating Parkinson’s diseases and other neurodegenerative disorders is getting medicine to the right place in the brain.
Boosting levels of two critical proteins that normally shut down during Huntington’s disease, researchers at UW-Madison and the Cold Spring Harbor Laboratory have cured fruit flies of the genetic, neurodegenerative condition.
Unveiling a delivery method that may one day help surgeons treat the deadly neurodegenerative disease amyotrophic lateral sclerosis (ALS), researchers at the UW-Madison have inserted engineered human stem cells into the spinal cords of ALS-afflicted rats.
Michael J. Fox visited the Waisman Center on Tuesday, February 1 to tour the stem cell research laboratories of Clive Svendsen and Su-Chun Zhang, as well as other components of the center’s translational research tower, including the Waisman Clinical BioManufacturing Facility and the Waisman Laboratory for Brain Imaging and Behavior. Fox was accompanied by Wisconsin Governor James Doyle.
A team of University of Wisconsin-Madison researchers have found a way to revive dying brain cells in lab mice, spurring hopes of combating major human neurological diseases.
In a finding that may cause a dramatic shift in the way scientists and researchers search for a therapy for Alzheimer’s disease, a team of researchers led by Jeff Johnson, an associate professor at the School of Pharmacy, has discovered that increased expression of a protein called transthyretin in the brain appears to halt the progression of the disease.
A gift of $500,000 from George E. Prescott, a member of the Waisman Center’s board of visitors, will benefit the Parkinson’s disease research program at the Waisman Center.
By pumping a potent growth factor directly into the human brain, an international team of scientists and surgeons has demonstrated significant remediation of the debilitating symptoms of patients with Parkinson’s disease.